'Large cell/anaplastic' medulloblastomas: A Pediatric Oncology Group study

Journal of Neuropathology and Experimental Neurology

Volumn 59, Issue 10, 2000, Pages 857-865

  Brown, Henry G ^a   Kepner, James L ^b   Perlman, Elizabeth J ^a   Friedman, Henry S ^c   Strother, Douglas R ^d   Duffner, Patricia K ^e   Kun, Larry E ^f   Goldthwaite, Patricia T ^a   Burger, Peter C ^a,g  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Statistical Office   (United States)

^c DUKE UNIVERSITY   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

^e ROSWELL PARK CANCER INSTITUTE   (United States)

^f ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^g JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Amplification; Brain tumor; c myc; Children; Large cell; Medulloblastoma; n myc

Indexed keywords

ANAPLASTIC CARCINOMA; ARTICLE; CANCER SURVIVAL; CELL ULTRASTRUCTURE; CHILD; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; HISTOPATHOLOGY; HUMAN; INFANT; ISOCHROMOSOME; LARGE CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MEDULLOBLASTOMA; ONCOGENE C MYB; ONCOGENE C MYC; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS;

EID: 0033791188     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnen/59.10.857     Document Type: Article

References (38)

1. Large-cell medulloblastomas. A distinct variant with highly aggressive behavior
2. Malignant rhabdoid tumor of the central nervous system
3. Atypical teratoid tumor of infancy: Definition of an entity
4. Rhabdoid tumor of the central nervous system
5. Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood
6. Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood: Definition of an entity
7. Atypical teratoid/rhabdoid tumor of the central nervous system: A highly malignant tumor of infancy and childhood frequently mistaken for medulloblastoma. A pediatric oncology group study
8. Kuhl molecular analysis of childhood primitive neuroectodermal tumors defines markers associated with poor outcome
9. Nonparametric estimation from incomplete observations
10. Design and analysis of clinical trials requiring prolonged observation of each patient. Analysis and examples
11. Quantitative analysis of comparative genomic hybridization
12. Genetic analysis of ovarian germ cell tumors by comparative genomic hybridization
13. Structural chromosomal abnormalities in human medulloblastoma
14. Isochromosome 17q in primitive neuroectodermal tumors of the central nervous system
15. Evidence for a 17p tumor related locus distinct from p53 in pediatric primitive neuroectodermal tumors
16. Physical mapping of chromosome 17q13.3 in the region of a putative tumor suppressor gene important in medulloblastoma
17. Mapping of chromosomal gains and losses in primitive neuroectodermal tumors by comparative genomic hybridization
18. Extensive genomic abnormalities in childhood medulloblastoma by comparative genomic hybridization
19. Prognostic significance of chromosome 17p deletions in childhood primitive neuroectodermal tumors (medulloblastomas) of the central nervous system
20. Monosomy 22 in rhabdoid or atypical tumors of the brain
21. Molecular cytogenetic analysis of a medulloblastoma with isochromosome 17 and double minutes
22. Prognostic implications of chromosome 17p deletions in human medulloblastomas
23. Phenotypic and genotypic analysis of a human medulloblastoma cell line and transplantable xenograft (D341 med) demonstrating amplification of c-myc
24. Amplification of the c-myc gene in human medulloblastoma cell lines and xenografts
25. The many roles of c-myc in apoptosis
26. Elevated c-myc expression in childhood medulloblastomas
27. Expression of the c-myc protein in childhood medulloblastoma
28. N-myc and c-myc oncogenes amplification in medulloblastomas. Evidence of particularly aggressive behavior of a tumor with c-myc amplification
29. N-myc gene expression and oncoprotein characterisation in medulloblastoma
30. N-myc amplification and neuronal differentiation in human primitive neuroectodermal tumors of the central nervous system
31. Aggressive medulloblastoma with high-level N-myc amplification
32. Multiple genomic alterations including N-myc amplifcation in a primary large-cell medulloblastoma
33. The molecular basis of Turcot's syndrome
34. Sporadic medulloblastomas contain oncogenic β-catenin mutations
35. Nuclear localization and mutation of β-catenin in medulloblastomas
36. Analysis of PTCH/SMO/SHH pathway genes in medulloblastoma
37. Medulloblastomas of the desmoplastic variant carry mutations of the human homologue of Drosophila patched
38. Somatic mutations in the human homologue of drosophila patched in primitive neuroectodermal tumours